These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33497739)

  • 1. Trilobatin ameliorates bone loss via suppression of osteoclast cell differentiation and bone resorptive function in vitro and in vivo.
    Kim SC; Kim HJ; Park GE; Pandey RP; Lee J; Sohng JK; Park YI
    Life Sci; 2021 Apr; 270():119074. PubMed ID: 33497739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfated Glucuronorhamnoxylan from Capsosiphon fulvescens Ameliorates Osteoporotic Bone Resorption via Inhibition of Osteoclastic Cell Differentiation and Function In Vitro and In Vivo.
    Kim SC; Kim HJ; Park GE; Lee CW; Synytsya A; Capek P; Park YI
    Mar Biotechnol (NY); 2022 Aug; 24(4):690-705. PubMed ID: 35796894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Puerarin specifically disrupts osteoclast activation via blocking integrin-β3 Pyk2/Src/Cbl signaling pathway.
    Qiu Z; Li L; Huang Y; Shi K; Zhang L; Huang C; Liang J; Zeng Q; Wang J; He X; Qin L; Wang X
    J Orthop Translat; 2022 Mar; 33():55-69. PubMed ID: 35228997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phloretin promotes osteoclast apoptosis in murine macrophages and inhibits estrogen deficiency-induced osteoporosis in mice.
    Lee EJ; Kim JL; Kim YH; Kang MK; Gong JH; Kang YH
    Phytomedicine; 2014 Sep; 21(10):1208-15. PubMed ID: 24932975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glaucocalyxin A suppresses osteoclastogenesis induced by RANKL and osteoporosis induced by ovariectomy by inhibiting the NF-κB and Akt pathways.
    Zhu M; Shan J; Xu H; Xia G; Xu Q; Quan K; Liu X; Dai M
    J Ethnopharmacol; 2021 Aug; 276():114176. PubMed ID: 33933570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fengshi Qutong capsule ameliorates bone destruction of experimental rheumatoid arthritis by inhibiting osteoclastogenesis.
    Li Y; Yang C; Jia K; Wang J; Wang J; Ming R; Xu T; Su X; Jing Y; Miao Y; Liu C; Lin N
    J Ethnopharmacol; 2022 Jan; 282():114602. PubMed ID: 34492323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-perimenopausal osteoporosis effects of Erzhi formula via regulation of bone resorption through osteoclast differentiation: A network pharmacology-integrated experimental study.
    Qin XY; Niu ZC; Han XL; Yang Y; Wei Q; Gao XX; An R; Han LF; Yang WZ; Chai LJ; Liu EW; Gao XM; Mao HP
    J Ethnopharmacol; 2021 Apr; 270():113815. PubMed ID: 33444724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel small molecule E0924G dually regulates bone formation and bone resorption through activating the PPARδ signaling pathway to prevent bone loss in ovariectomized rats and senile mice.
    Li Y; Liu C; Han X; Sheng R; Bao L; Lei L; Wu Y; Li Q; Zhang Y; Zhang J; Wang W; Zhang Y; Li S; Wang C; Wei X; Wang J; Peng Z; Xu Y; Si S
    Bioorg Chem; 2024 Jun; 147():107364. PubMed ID: 38636434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longan fruit increase bone mineral density in zebrafish and ovariectomized rat by suppressing RANKL-induced osteoclast differentiation.
    Son Y; Lee EM; Lee DY; Lee JH; Oh S
    Phytomedicine; 2019 Jun; 59():152910. PubMed ID: 30978650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonate-enoxacin inhibit osteoclast formation and function by abrogating RANKL-induced JNK signalling pathways during osteoporosis treatment.
    Xu Q; Zhan P; Li X; Mo F; Xu H; Liu Y; Lai Q; Zhang B; Dai M; Liu X
    J Cell Mol Med; 2021 Nov; 25(21):10126-10139. PubMed ID: 34651433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Onion (
    Zhang D; Wang X; Sun K; Guo J; Zhao J; Dong Y; Bao Y
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anethole inhibits RANKL-induced osteoclastogenesis by downregulating ERK/AKT signaling and prevents ovariectomy-induced bone loss in vivo.
    Qu H; Zhang Y; He R; Lin N; Wang C
    Int Immunopharmacol; 2021 Nov; 100():108113. PubMed ID: 34530203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chaenomelis fructus inhibits osteoclast differentiation by suppressing NFATc1 expression and prevents ovariectomy-induced osteoporosis.
    Kim M; Kim HS; Kim JH; Kim EY; Lee B; Lee SY; Jun JY; Kim MB; Sohn Y; Jung HS
    BMC Complement Med Ther; 2020 Feb; 20(1):35. PubMed ID: 32024503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flavonoids compounds from Tridax procumbens inhibit osteoclast differentiation by down-regulating c-Fos activation.
    Al Mamun MA; Asim MMH; Sahin MAZ; Al-Bari MAA
    J Cell Mol Med; 2020 Feb; 24(4):2542-2551. PubMed ID: 31919976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential anti-osteoporotic activity of low-molecular weight hyaluronan by attenuation of osteoclast cell differentiation and function in vitro.
    Lee CW; Seo JY; Choi JW; Lee J; Park JW; Lee JY; Hwang KY; Park YS; Park YI
    Biochem Biophys Res Commun; 2014 Jul; 449(4):438-43. PubMed ID: 24853804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WSS25, a sulfated polysaccharide, inhibits RANKL-induced mouse osteoclast formation by blocking SMAD/ID1 signaling.
    Chen C; Qin Y; Fang JP; Ni XY; Yao J; Wang HY; Ding K
    Acta Pharmacol Sin; 2015 Sep; 36(9):1053-64. PubMed ID: 26299951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin Inhibits Osteoclastogenesis and Bone Loss in Ovariectomized Mice by Regulating PRMT1-Mediated Signaling.
    Choi JH; Jang AR; Park MJ; Kim DI; Park JH
    Endocrinology; 2021 Jun; 162(6):. PubMed ID: 33713122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xanthotoxin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis.
    Dou C; Chen Y; Ding N; Li N; Jiang H; Zhao C; Kang F; Cao Z; Quan H; Luo F; Xu J; Dong S
    Osteoporos Int; 2016 Jul; 27(7):2335-2344. PubMed ID: 26809192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethanol extract of Polyscias fruticosa leaves suppresses RANKL-mediated osteoclastogenesis in vitro and LPS-induced bone loss in vivo.
    Tran PT; Dang NH; Kim O; Van Cuong P; Dat NT; Hwangbo C; Van Minh C; Lee JH
    Phytomedicine; 2019 Jun; 59():152908. PubMed ID: 30981187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hyperoside on osteoporosis in ovariectomized mice through estrogen receptor α/ITGβ3 signaling pathway.
    Wei Q; Ouyang M; Guo X; Fu X; Liu T; Luo Y; Tang H; Yang Y; Gao X; Mao H
    Eur J Pharmacol; 2024 Aug; 977():176666. PubMed ID: 38797313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.